ArticleScientific reports2025
Comparison of real-time PCR and nCounter NanoString techniques to validate copy number alterations in oral cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of NanoString Technologies in Chronic Myeloid Leukemia, Essential Thrombocythemia, Primary Myelofibrosis, and Polycythemia Vera: A Pilot Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Copy number alterations (CNAs) are imperative in determining the patient's prognostic and predictive status. Real-time polymerase chain reaction (PCR) is extensively used to validate the results of global genomic profiling methods. However, nCounter NanoString is yet to be thoroughly assessed and compared for copy number analysis. For the first time, we have comprehensively compared the aforementioned techniques in 119 oral cancer samples to evaluate 24 genes. Spearman's rank correlation and Cohen's Kappa score were calculated to identify concurrence. Kaplan-Meier curves with the Log-rank test were used to identify genes related to disease prognosis, including recurrence-free survival (RFS), disease-specific survival (DSS), and overall survival (OS). Spearman's rank correlation ranged from r = 0.188 to 0.517, and Cohen's kappa score showed a moderate to substantial agreement. Additionally, in real-time PCR, ISG15 was associated with a better prognosis for RFS, DSS and OS, along with ATM, CASP4, and CYB5A with poor RFS. However, in nCounter NanoString, ISG15 was associated with poor prognosis for RFS, DSS, and OS, while CDK11A showed poor prognosis for RFS. Real-time PCR remains a robust method to validate the genomic biomarkers. However, these observations should be rigorously validated by conducting additional, well-designed, independent studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.